Robert D Morgan

18PUBLICATIONS
59CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 25, 2026
Risk of breast cancer after ovarian cancer in germline BRCA1/2 heterozygotes.

|Nov 19, 2025
Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer.

D Gareth Evans, Robert D Morgan, Claire Forde

|Nov 16, 2024
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

Robert D Morgan, Xin Wang, Bethany M Barnes

|Sep 02, 2024
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom.

Elaine Yl Leung, Shibani Nicum, Jo Morrison

|Jul 17, 2024
Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation.

Camilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes

|May 09, 2024
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.

Alexander D Murphy, Catharine Porter, Ann White

Pageof 3

Frequent Collaborators

9 joint publications

D Gareth R Evans

6 joint publications

George J Burghel

4 joint publications

Gordon C Jayson

4 joint publications

Andrew R Clamp